The North American inhalable drug market is anticipated to grow at a CAGR of 2.8% over the forecast period (2020-2026). The key factors that drive the growth of the inhalable drugs industry is the rising prevalence of various respiratory and non- respiratory diseases that create the demand for inhalable drugs. Further, the increasing geriatric population who find […]
